- Investing Ideas
- Swiss Top Stock Picks from Analysts
Swiss Top Stock Picks from Analysts
Results
13
Companies which are more than 50% undervalued based on analyst price target.
13 companies
SMG Swiss Marketplace Group Holding
Market Cap: CHF 2.8b
An online marketplace and digital company, provides tools for decision making in Switzerland.
SMG
CHF 29.00
7D
-11.0%
1Y
n/a
ALSO Holding
Market Cap: CHF 1.6b
Operates as a technology services provider for the ICT industry in Switzerland, Germany, the Netherlands, Poland, and internationally.
ALSN
CHF 133.40
7D
-35.1%
1Y
-47.5%
naturenergie holding
Market Cap: CHF 1.1b
Through its subsidiaries, engages in the production, distribution, and sale of electricity under the Naturenergie brand in Switzerland and internationally.
NEAG
CHF 33.10
7D
-0.6%
1Y
-4.1%
Basilea Pharmaceutica
Market Cap: CHF 675.8m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 55.00
7D
-6.0%
1Y
24.3%
Newron Pharmaceuticals
Market Cap: CHF 420.3m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 21.00
7D
4.7%
1Y
95.9%
Mikron Holding
Market Cap: CHF 284.6m
Develops, produces, and markets automation solutions, machining systems, and cutting tools in the Switzerland, Europe, North America, the Asia Pacific, and internationally.
MIKN
CHF 17.08
7D
-2.3%
1Y
13.9%
Santhera Pharmaceuticals Holding
Market Cap: CHF 237.9m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANN
CHF 17.08
7D
20.5%
1Y
2.9%
Varia US Properties
Market Cap: CHF 185.8m
A real estate investment company, acquires, holds, and sells properties in the United States.
VARN
CHF 18.35
7D
-8.3%
1Y
-36.3%
MindMaze Therapeutics Holding
Market Cap: CHF 159.0m
Develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology.
MMTX
CHF 1.04
7D
-6.8%
1Y
n/a
BioVersys
Market Cap: CHF 137.4m
A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.
BIOV
CHF 23.50
7D
0%
1Y
-32.6%
Molecular Partners
Market Cap: CHF 136.7m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 3.66
7D
3.0%
1Y
-18.8%
Curatis Holding
Market Cap: CHF 91.0m
Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
CURN
CHF 17.65
7D
4.4%
1Y
56.9%
Asmallworld
Market Cap: CHF 9.2m
Operates a digital travel and lifestyle ecosystem worldwide.
ASWN
CHF 0.64
7D
-3.8%
1Y
-53.3%